The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Gene Review

EPO  -  erythropoietin

Sus scrofa

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of EPO

  • Differences among the treatment groups included a lower fetal survival percentage in UHO (vs. INT or MS) on Day 40, and higher maternal hematocrits, fetal weights, fetal hematocrits, fetal EPO levels, and liver transferrin secretion in WC vs. MS pigs [1].
  • The mechanisms, however, by which EPO may cause hypertension are still unclear [2].
  • Quantitative histological analysis of the ischaemic regions revealed a reduction of myocardial fibrosis (8% vs. 28%) in the EPO group [3].
  • However, the hearing loss of the EPO treated animals was significantly worse than controls in trial 2 [4].
  • Latency characteristics of an EPO and LLT mutant of pseudorabies virus [5].
 

Psychiatry related information on EPO

  • In addition, the need for a more systematic longitudinal assessment of dementia in dialysis patients by standardized neuropsychologic testing, testing blood levels and glycosylated isoforms of PGD(2)S, and the effect of COX inhibition and erythropoietin administration on dialysis dementia are discussed [6].
 

High impact information on EPO

  • Nanogram concentrations of the growth hormones potentiated erythropoietin-stimulated erythropoiesis, but not granulopoiesis, in a species-specific manner [7].
  • Activity with physiologic concentrations of chloride was favored by a relatively high EPO level, a decrease in pH below neutrality and an absence of extraneous protein [8].
  • When the EPO concentration of the reaction mixture was lowered, the bactericidal effect at pH 7.0 was lost first with chloride, then with bromide, and finally with iodide as the halide [8].
  • Increased fetal weight, fetal liver weight, placental weight, total red blood cells, hematocrit, blood hemoglobin content, and maternal plasma erythropoietin (EPO) levels were observed as gestation advanced [1].
  • CONCLUSION: Endocardial EPO injection may induce cardioprotective effects in hibernating myocardium and may attenuate the progression of ischaemic tissue damage [3].
 

Chemical compound and disease context of EPO

 

Biological context of EPO

  • BACKGROUND: Apart from its well-known stimulation of erythropoiesis, erythropoietin (EPO) exhibits angiogenic and anti-apoptotic effects [3].
  • A rise in blood pressure is the main side effect of erythropoietin (EPO) treatment in patients with renal anemia [2].
  • In a second study at day 35 of gestation, embryonic liver EPO mRNA expression was measured in the same three pig models and in two embryos of divergent weights from each gilt [11].
  • There was no apparent relationship between embryonic development, measured as embryonic and placental size, and plasma EPO concentrations or liver EPO mRNA expression [11].
  • EPO administration may alter the blood flow dynamics of the cochlear vascular bed during or after noise exposure, by a potential induction of vasoconstriction [4].
 

Anatomical context of EPO

  • The testes showed a higher ratio of EPO mRNA to total RNA than the liver [12].
  • Spleen showed very low levels of expression, while no expression of erythropoietin mRNA was detected in brain tissue, bone marrow, lung, lymph nodes, and ovaries [12].
  • We therefore investigated the effects of EPO on endothelin (ET) synthesis and cytosolic free calcium concentration ([Ca2+]i) in vascular endothelial cells [2].
  • An erythropoietin (EPO) assay showed that all nine transgenic lines carrying the 8.8 kb construct expressed recombinant human erythropoietin (rhEPO) only in their urethra and bladder, whereas two transgenic lines carrying the 2.1 kb pUPII promoter displayed hEPO expression in several organs including bladder, kidney, spleen, heart, and brain [13].
  • We hypothesize on the existence of a local paracrine system and that EPO treatment may be feasible following inner ear damage [14].
 

Associations of EPO with chemical compounds

 

Regulatory relationships of EPO

 

Other interactions of EPO

 

Analytical, diagnostic and therapeutic context of EPO

  • Expression analyses using a competitive RT-PCR assay showed that the kidneys contain about ten times more erythropoietin mRNA than the liver in five-week-old piglets, thus indicating that the shift from mainly hepatic to mainly renal EPO production has taken place at this age [12].
  • RESULTS: Endocardial electromechanical mapping showed an increase of mean unipolar voltage (UV) amplitude in the ischaemic myocardial segments in the EPO-treated animals (8.5 mV pre and 10.6 mV post treatment) and a significantly reduced ischaemic surface area compared to the control group (19% vs. 41%) suggesting a decline in ischaemic injury [3].
  • A partial cDNA for porcine EPO, developed via reverse transcription and polymerase chain reaction procedures was used to generate a 32P-labeled probe for use in Northern analyses [11].
  • Normal guinea pig inner ears were processed for immunohistochemistry, using poly-clonal antibodies against EPO and the EPO receptor [14].
  • Liver EPO mRNA expression did not differ among animal models, nor did plasma EPO or tissue EPO mRNA expression differ between large and small embryos [11].

References

  1. Uterine environment and breed effects on erythropoiesis and liver protein secretion in late embryonic and early fetal swine. Pearson, P.L., Klemcke, H.G., Christenson, R.K., Vallet, J.L. Biol. Reprod. (1998) [Pubmed]
  2. Effects of erythropoietin on endothelin-1 synthesis and the cellular calcium messenger system in vascular endothelial cells. Vogel, V., Kramer, H.J., Bäcker, A., Meyer-Lehnert, H., Jelkmann, W., Fandrey, J. Am. J. Hypertens. (1997) [Pubmed]
  3. Percutaneous endocardial injection of erythropoietin: assessment of cardioprotection by electromechanical mapping. Krause, K.T., Jaquet, K., Geidel, S., Schneider, C., Mandel, C., Stoll, H.P., Hertting, K., Harle, T., Kuck, K.H. Eur. J. Heart Fail. (2006) [Pubmed]
  4. Does erythropoietin augment noise induced hearing loss? Frederiksen, B.L., Cay??-Thomasen, P., Lund, S.P., Wagner, N., Asal, K., Olsen, N.V., Thomsen, J. Hear. Res. (2007) [Pubmed]
  5. Latency characteristics of an EPO and LLT mutant of pseudorabies virus. Cheung, A.K. J. Vet. Diagn. Invest. (1996) [Pubmed]
  6. Contribution of prostaglandin D2 synthase to progression of renal failure and dialysis dementia. Maesaka, J.K., Palaia, T., Fishbane, S., Ragolia, L. Semin. Nephrol. (2002) [Pubmed]
  7. Growth hormone: species-specific stimulation of erythropoiesis in vitro. Golde, D.W., Bersch, N., Li, C.H. Science (1977) [Pubmed]
  8. Bactericidal activity of eosinophil peroxidase. Jong, E.C., Henderson, W.R., Klebanoff, S.J. J. Immunol. (1980) [Pubmed]
  9. Potential neuroprotective benefits of erythropoietin during experimental hypothermic circulatory arrest. Romsi, P., Rönkä, E., Kiviluoma, K., Vainionpää, V., Hirvonen, J., Mennander, A., Pokela, M., Biancari, F., Rimpiläinen, J., Juvonen, T. J. Thorac. Cardiovasc. Surg. (2002) [Pubmed]
  10. Upregulation of hypoxia inducible factor is associated with attenuation of neuronal injury in neonatal piglets undergoing deep hypothermic circulatory arrest. Kerendi, F., Halkos, M.E., Kin, H., Corvera, J.S., Brat, D.J., Wagner, M.B., Vinten-Johansen, J., Zhao, Z.Q., Forbess, J.M., Kanter, K.R., Kelley, M.E., Kirshbom, P.M. J. Thorac. Cardiovasc. Surg. (2005) [Pubmed]
  11. Erythropoietin mRNA expression in pig embryos. Klemcke, H.G., Vallet, J.L., Christenson, R.K., Pearson, P.L. Anim. Reprod. Sci. (2001) [Pubmed]
  12. The porcine erythropoietin gene: cDNA sequence, genomic sequence and expression analyses in piglets. David, R.B., Blom, A.K., Sjaastad, O.V., Harbitz, I. Domest. Anim. Endocrinol. (2001) [Pubmed]
  13. Cloning and molecular dissection of the 8.8 kb pig uroplakin II promoter using transgenic mice and RT4 cells. Kwon, D.N., Choi, Y.J., Park, J.Y., Cho, S.K., Kim, M.O., Lee, H.T., Kim, J.H. J. Cell. Biochem. (2006) [Pubmed]
  14. Erythropoietin and erythropoietin receptor expression in the guinea pig inner ear. Cayé-Thomasen, P., Wagner, N., Lidegaard Frederiksen, B., Asal, K., Thomsen, J. Hear. Res. (2005) [Pubmed]
  15. Ototoxicity of ethanol in the tympanic cleft in animals. Morizono, T., Sikora, M.A. Acta Otolaryngol. (1981) [Pubmed]
  16. Erythropoietin-induced proliferation of gastric mucosal cells. Itoh, K., Sawasaki, Y., Takeuchi, K., Kato, S., Imai, N., Kato, Y., Shibata, N., Kobayashi, M., Moriguchi, Y., Higuchi, M., Ishihata, F., Sudoh, Y., Miura, S. World J. Gastroenterol. (2006) [Pubmed]
  17. Induction of hypoxia-inducible-factor 1 by nitric oxide is mediated via the PI 3K pathway. Sandau, K.B., Faus, H.G., Brüne, B. Biochem. Biophys. Res. Commun. (2000) [Pubmed]
 
WikiGenes - Universities